Filter

41 - 50 of 227 Results

  • Major Federal and State Funding Cuts Facing Planned Parenthood

    Issue Brief

    This issue brief presents data from the most recent tracking poll asking if people have ever visited a Planned Parenthood clinic for health care services and looks at the funding cuts Planned Parenthood is currently facing including Medicaid, Title X, and Teen Pregnancy Prevention funds.

  • The Impact of Medicaid and Title X on Planned Parenthood

    Issue Brief

    This KFF analysis demonstrates the impact the exclusion of Planned Parenthood from Medicaid and the Title X funding freeze may have on low-income and uninsured individuals who get their family planning care at Planned Parenthood.

  • Rebuilding the Title X Network Under the Biden Administration

    Issue Brief

    This issue brief examines what has happened to the Title X network under the Biden Administration regulations, including the number of clinics that have returned to the network, new funding, and how state policies that prohibit pregnancy options counseling that includes abortion and referrals may impact grantees' participation in the Title X program.

  • Will Trump’s Announcement Expand Access to IVF? 

    Policy Watch

    The White House announcement focused on reducing the cost of some IVF drugs and clarifying options for employers to offer standalone fertility benefits for their employees and their dependents. This policy watch examines some key takeaways about the Trump IVF plan.

  • KFF Health Tracking Poll March 2024: Abortion in the 2024 Election and Beyond

    Feature

    This poll finds 1 in 8 voters say abortion is the most important issue to their vote. They are younger, lean Democratic, and generally want abortion to be legal in all or most cases. The poll also gauges the public's views on abortion-related policies, including a national 16-week abortion ban and allowing abortion for pregnancy-related emergencies.

  • KFF Examines Key Considerations for the Implementation of Insurance Coverage for Over-the-Counter Contraceptives

    News Release

    With federal regulators seeking public input on the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover over-the-counter preventive products without a prescription, a new KFF post explores the issues relevant to covering over-the-counter contraceptives. These contraceptives include Opill, the first daily oral contraceptive pill to receive FDA approval for over-the-counter availability. The analysis draws on the lessons learned from KFF staff interviews with more than 80 key players nationally…